Anavex Life Sciences Corp (AVXL)

[jmvho]

I just watched today's Needham presentation and something that caught my attention was the slide showing the global market opportunity for CNS disorders at $232.B and the number of estimated CNS patients globally at 67.5 million which equates to an annual per patient charge of $3,440. So,
we're back to basically $10 per day per patient for financial modeling purposes. Per the usual differentiation between various countries/regions, I'm
sure 2-73 will be commanding a higher price here in the U.S. than elsewhere.

Overall, I felt it was a very good presentation and I believe a lot of other companies would kill for half the pipeline potential of Anavex. I'm firmly convinced this company is a giant in the making!

jmvho